Related Experiment Videos
Glucose production and utilization in children with glycogen storage disease type I
Insights
Children with glycogen storage disease type I (GSD I) exhibit reduced glucose production rates, similar to normal children after a 30-hour fast. Their glucose utilization is higher, contributing to hypoglycemia.
Area of Science:
- Biochemistry
- Pediatric Endocrinology
- Metabolic Disorders
Background:
- Glycogen storage disease type I (GSD I) is a metabolic disorder characterized by hypoglycemia.
- Understanding glucose metabolism is crucial for managing GSD I complications.
Purpose of the Study:
- To investigate whether hypoglycemia in GSD I is caused by decreased glucose production or increased glucose utilization.
- To quantify glucose turnover rates in children with GSD I.
Main Methods:
- Utilized [2H2]glucose tracer to estimate glucose turnover rates in five children with GSD I.
- Sequentially reduced exogenous glucose infusion rates to observe effects on endogenous glucose production and utilization.
- Compared results with data from normal children under varying fasting conditions.
Main Results:
- Children with GSD I showed significantly lower endogenous glucose production rates (3.9 mg X kg-1 X min-1) compared to overnight-fasted normal children (6.3 mg X kg-1 X min-1).
- Glucose production rates in GSD I were comparable to normal children fasted for 30 hours.
- Glucose utilization rates were elevated in GSD I patients, even with lower plasma glucose concentrations.
Conclusions:
- Hypoglycemia in GSD I is attributed to a combination of reduced glucose production and increased glucose utilization.
- Impaired endogenous glucose production in GSD I is a significant factor contributing to their metabolic derangements.
Abstract:
Glucose turnover rates were estimated with [2H2]glucose in five children with glycogen storage disease type I (GSD I) during sequential withdrawal of an infusion of glucose to determine whether their hypoglycemia was the result of decreased glucose production or increased rates of glucose utilization. Plasma glucose concentrations were 78 +/- 5 mg/dl during infusion of glucose at 6 mg X kg-1 X min-1 and decreased to 53 +/- 3 and 45 +/- 7 mg/dl during the 3 and 1.5 mg X kg-1 X min-1 glucose infusions, respectively. Total glucose flux during the 6 mg X kg-1 X min-1 glucose infusion was 7.3 +/- 0.7 mg X kg-1 X min-1 and decreased with reduction in the rate of glucose infused. Endogenous glucose production increased with each decrease in the rate of exogenous glucose infused. Following discontinuation of glucose infusion, endogenous glucose production was 3.9 +/- 0.3 mg X kg-1 X min-1, a value that was lower (P less than 0.05) than that observed in overnight-fasted normal children (6.3 +/- 0.3 mg X kg-1 X min-1) but not statistically different from the Ra of normal children fasted for 30 h (4.1 +/- 0.5 mg X kg-1 X min-1). Thus, children with GSD have glucose production rates that are 40% lower than those of normal children fasted overnight but equal to those of normal children fasted 30 h. Rates of glucose utilization during the 6 mg X kg-1 X min-1 glucose infusion were higher (0.05 less than P less than 0.1) than those of overnight-fasted normal children, despite lower plasma glucose concentrations when expressed on a body weight basis but not when expressed on the basis of estimated brain weight.(ABSTRACT TRUNCATED AT 250 WORDS)